Table 1. Baseline characteristics and Outcome measures.
Overall population (n=24,508) | Dead at Hospital Discharge (n=3,002) | Alive at Hospital Discharge (n=21,506) | |
---|---|---|---|
Age | 65 [51–77] | 74 [59–83] | 64 [50–76] |
Gender (female) | 13,838 (56.5%) | 1,607 (53.5%) | 12231 (56.9%) |
First SAPS | 13 [10–17] | 18 [14–22] | 13 [9–17] |
First SAPS II | 38 [27–51] | 53 [43–64] | 36 [27–49] |
First SOFA | 5 [2–8] | 8 [5–12] | 5 [2–8] |
Origin | |||
Medical | 2,453 (10%) | 240 (8%) | 2,213 (10.3%) |
Trauma | 7,703 (31.4%) | 1,055 (35.1%) | 6,648 (30.9%) |
Emergency Surgery | 10,803 (44.1%) | 1,583 (52.7%) | 9,220 (42.9%) |
Scheduled Surgery | 3,549 (14.5%) | 124 (4.1%) | 3,425 (15.9%) |
Site | |||
MICU | 7,488 (30.6%) | 1,265 (42.1%) | 6,223 (28.9%) |
MSICU | 2,686 (11%) | 347 (11.6%) | 2,339 (10.9%) |
CCU | 5,285 (21.6%) | 633 (21.1%) | 4,652 (21.6%) |
CSRU | 8,100 (33.1%) | 664 (22.1%) | 7,436 (34.6%) |
TSICU | 949 (3.9%) | 93 (3.1%) | 856 (4%) |
HR (bpm) | 87 [75–100] | 92 [78–109] | 86 [75–99] |
MAP (mmHg) | 81 [70–94] | 78 [65–94] | 82 [71–94] |
RR (cpm) | 14 [12–20] | 18 [14–23] | 14 [12–18] |
Na (mmol/l) | 139 [136–141] | 138 [135–141] | 139 [136–141] |
K (mmol/l) | 4.2 [3.8–4.6] | 4.2 [3.8–4.8] | 4.2 [3.8–4.6] |
HCO3 (mmol/l) | 26 [22–28] | 24 [20–28] | 26 [23–28] |
WBC (103/mm3) | 10.3 [7.5–14.4] | 11.6 [7.9–16.9] | 10.2 [7.4–14.1] |
P/F ratio | 281 [130–447] | 174 [90–352] | 312 [145–461] |
Ht (%) | 34.7 [30.4–39] | 33.8 [29.8–38] | 34.8 [30.5–39.1] |
Urea (mmol/l) | 20 [14–31] | 28 [18–46] | 19 [13–29] |
Bilirubine (mg/dl) | 0.6 [0.4–1] | 0.7 [0.4–1.5] | 0.6 [0.4–0.9] |
Hospital LOS (days) | 8 [4–14] | 9 [4–17] | 8 [4–14] |
ICU death (%) | 1,978 (8.1%) | 1,978 (65.9% | - |
Hospital death (%) | 3,002 (12.2%) | - | - |